Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole and reflux disease - improvement of clinical outcome by genotype-adjusted dosing
2006-004650-24Phase 4Terminated
- Sponsor
- IKP Knowledge Park
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by IKP Knowledge Park. Primary endpoint: Endoscopic healing rates. Started Dec 2006; status: terminated.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-004650-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004650-24.